Nobel Prize-winning research identified genes (Yamanaka factors) that revert specialized adult cells back into their embryonic, stem-cell state. This discovery proves cellular differentiation and aging are not irreversible, opening the door for regenerative therapies by "rebooting" cells to an earlier state.

Similar to aging, cancer is a state where cells lose their original identity. By applying age-reversal technologies, cancer cells can be forced to become normal again or even self-destruct, offering a novel approach to cancer treatment.

To pioneer treatments in the new field of aging, the company's strategy is to create new combinations from existing products with established human safety profiles. This adheres to a strict "do no harm" principle, significantly reducing the safety risk and regulatory uncertainty inherent in developing entirely new chemical entities for a preventative, long-term indication.

Aging is not wear and tear, but a loss of epigenetic information. Cells lose their identity, akin to corrupted software. The body holds a "backup copy" of youthful information that can be reinstalled, fundamentally making age reversal possible.

The book posits that aging is a loss of epigenetic information, not an irreversible degradation of our DNA. Our cells' "software" forgets how to read the "hardware" (DNA) correctly. This suggests aging can be rebooted, much like restoring a computer's operating system.

Aging is framed as a software problem, not a hardware one. Cells lose the ability to read the correct genetic information over time, but a theoretical "backup copy" of the original youthful state exists and can be accessed to reverse the process.

George Church predicts that reversing aging via somatic gene therapy will be the first truly mainstream genetic enhancement. Since aging will affect 90% of the population, therapies that restore youthful function in the elderly will have a massive impact and widespread adoption, becoming the "GLP-1 moment" for gene editing.

The scientific consensus is shifting: aging is not random decay but a predictable process of epigenetic errors. Over time, the molecular "switches" that turn genes on and off get scrambled. Technologies like Yamanaka factors can reset these switches, effectively reverting cells to a youthful state and reversing age-related diseases.

Reversing the age of a mouse retina surprisingly caused the spontaneous clearance of protein buildups associated with macular degeneration. This suggests that restoring a cell's youthful epigenetic state also reactivates its innate ability to clean and repair itself, a promising sign for treating diseases like Alzheimer's.